首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Development of a Novel Floating In-situ Gelling System for Stomach Specific Drug Delivery of the Narrow Absorption Window Drug Baclofen
【2h】

Development of a Novel Floating In-situ Gelling System for Stomach Specific Drug Delivery of the Narrow Absorption Window Drug Baclofen

机译:新型的浮动原位胶凝系统用于窄吸收窗药物Baclofen的胃特异性药物输送的开发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study deals with development of a floating in-situ gel of the narrow absorption window drug baclofen. Sodium alginate-based in-situ gelling systems were prepared by dissolving various concentrations of sodium alginate in deionized water, to which varying concentrations of drug and calcium bicarbonate were added. Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) were used to check the presence of any interaction between the drug and the excipients. A 32 full factorial design was used for optimization. The concentrations of sodium alginate (X1) and calcium bicarbonate (X2) were selected as the independent variables. The amount of the drug released after 1 h (Q1) and 10 h (Q10) and the viscosity of the solution were selected as the dependent variables. The gels were studied for their viscosity, in-vitro buoyancy and drug release. Contour plots were drawn for each dependent variable and check-point batches were prepared in order to get desirable release profiles. The drug release profiles were fitted into different kinetic models. The floating lag time and floating time found to be 2 min and 12 h respectively. A decreasing trend in drug release was observed with increasing concentrations of CaCO3. The computed values of Q1 and Q10 for the check-point batch were 25% and 86% respectively, compared to the experimental values of 27.1% and 88.34%. The similarity factor (f2) for the check-point batch being 80.25 showed that the two dissolution profiles were similar. The drug release from the in-situ gel follows the Higuchi model, which indicates a diffusion-controlled release. A stomach specific in-situ gel of baclofen could be prepared using floating mechanism to increase the residence time of the drug in stomach and thereby increase the absorption.
机译:本研究涉及窄吸收窗药物巴氯芬的浮动原位凝胶的开发。通过将各种浓度的海藻酸钠溶解在去离子水中来制备基于海藻酸钠的原位胶凝系统,并向其中添加不同浓度的药物和碳酸氢钙。傅里叶变换红外光谱(FTIR)和差示扫描量热法(DSC)用于检查药物和赋形剂之间是否存在任何相互作用。 3 2 全因子设计用于优化。选择海藻酸钠(X1)和碳酸氢钙(X2)的浓度作为自变量。选择1小时(Q1)和10小时(Q10)后释放的药物量和溶液的粘度作为因变量。研究了凝胶的粘度,体外浮力和药物释放。为每个因变量绘制轮廓图,并准备检查点批次以获得所需的释放曲线。药物释放曲线适合不同的动力学模型。漂浮滞后时间和漂浮时间分别为2分钟和12小时。随着CaCO3浓度的增加,观察到药物释放的减少趋势。对于检查点批次,Q1和Q10的计算值分别为25%和86%,而实验值分别为27.1%和88.34%。检查点批次的相似因子(f2)为80.25,表明两个溶出曲线相似。从原位凝胶释放的药物遵循Higuchi模型,表明扩散控制释放。可以使用漂浮机制来制备巴氯芬的胃特异性原位凝胶,以增加药物在胃中的停留时间,从而增加吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号